Abstract
The pure enantiomers of the N-(2-, 3-, and 4-(2-aminocyclopropyl)phenyl)benzamides hydrochlorides 11a-j were prepared and tested against LSD1 and MAO enzymes. The evaluation of the regioisomers 11a-j highlighted a net increase of the anti-LSD1 potency by shifting the benzamide moiety from ortho to meta and mainly to para position of tranylcypromine phenyl ring, independently from their trans or cis stereochemistry. In particular, the para-substituted 11a,b (trans) and 11g,h (cis) compounds displayed LSD1 and MAO-A inhibition at low nanomolar levels, while were less potent against MAO-B. The meta analogs 11c,d (trans) and 11i,j (cis) were in general less potent, but more efficient against MAO-A than against LSD1. In cellular assays, all the para and meta enantiomers were able to inhibit LSD1 by inducing Gfi-1b and ITGAM gene expression, with 11b,c and 11g-i giving the highest effects. Moreover, 11b and 11g,h strongly inhibited the clonogenic potential of murine promyelocytic blasts.
References
Aug 23, 2001·Neuron·N BallasG Mandel
Sep 28, 2002·Blood·Saverio MinucciPier Giuseppe Pelicci
Apr 18, 2003·Nature·Yujiang ShiYang Shi
Dec 29, 2004·Cell·Yujiang ShiYang Shi
Feb 6, 2007·Nature Cell Biology·Melanie WissmannRoland Schüle
Feb 13, 2007·Trends in Biochemical Sciences·Woon Ki PaikSangduk Kim
Feb 27, 2007·Cell·Bradley E BernsteinEric S Lander
Apr 27, 2007·ChemMedChem·Antonello MaiMark T Bedford
Mar 18, 2008·Trends in Biochemical Sciences·Federico FornerisAndrea Mattevi
Aug 26, 2009·Cell·Yan WangYongfeng Shang
Jan 1, 2010·Carcinogenesis·Soyoung LimJutta Kirfel
Jan 22, 2010·ChemMedChem·Sabrina CastellanoGianluca Sbardella
Jun 24, 2010·Biochemistry·Shinya MimasuShigeyuki Yokoyama
Sep 24, 2010·Leukemia·L T van der MeerB A van der Reijden
Oct 5, 2010·Cell Stem Cell·Daniela PalaciosPier Lorenzo Puri
Sep 24, 2011·Genes & Cancer·Dante Rotili, Antonello Mai
Apr 3, 2012·Cancer Cell·William J HarrisTim C P Somervaille
Jun 20, 2012·Biochimie·Sergio ValenteAntonello Mai
Oct 12, 2012·Cancer Research·Giovanna Ferrari-AmorottiBruno Calabretta
Jan 12, 2013·PloS One·Asif H ChowdhuryShireen Saleque
Mar 28, 2013·MBio·Timothy D ReadDeborah Dean
Jun 1, 2013·ACS Chemical Biology·Marcello TortoriciAndrea Mattevi
Nov 12, 2013·Oncogene·R CiarapicaR Rota
Mar 1, 2014·BMC Cancer·Roberta CiarapicaRossella Rota
Apr 9, 2014·ACS Chemical Biology·Polina PrusevichPhilip A Cole
Apr 15, 2014·Cell·Mario L SuvàBradley E Bernstein
Citations
Dec 29, 2015·Journal of Medicinal Chemistry·Tom E McAllisterChristopher J Schofield
Dec 26, 2015·Journal of Medicinal Chemistry·Paola VianelloCiro Mercurio
Dec 10, 2015·Epigenomics·Xueshun WangPeng Zhan
Jul 24, 2015·Journal of Proteome Research·Lijuan YangTong Wang
Apr 23, 2016·Epigenomics·Yi-Chao ZhengHong-Min Liu
Apr 23, 2016·International Journal of Molecular Sciences·David Ramírez, Julio Caballero
Feb 12, 2017·Journal of Medicinal Chemistry·Paola VianelloCiro Mercurio
Jan 5, 2017·Cold Spring Harbor Perspectives in Medicine·Ashwini JambhekarYang Shi
Jul 20, 2017·Future Medicinal Chemistry·Paolo TrifiròPaola Vianello
Feb 1, 2020·ChemMedChem·Rossella FioravantiAntonello Mai
Mar 10, 2017·Epigenetics : Official Journal of the DNA Methylation Society·Hideaki Niwa, Takashi Umehara
Jun 21, 2019·Medicinal Research Reviews·Daniela TomaselliAntonello Mai
Dec 15, 2020·Journal of Enzyme Inhibition and Medicinal Chemistry·Yang LiGuojun Zhang
Oct 21, 2020·European Journal of Medicinal Chemistry·Amr K A BassGamal El-Din A Abuo-Rahma
Dec 8, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Shujing ZhangHongmin Liu
Aug 30, 2018·Bioorganic & Medicinal Chemistry·Siyuan XuXiaoming Zha